Search hospitals > Colorado > Fort Collins

Poudre Valley Hospital

Claim this profile
Fort Collins, Colorado 80524
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Prostate Cancer
Conducts research for Cancer
276 reported clinical trials
29 medical researchers
Photo of Poudre Valley Hospital in Fort CollinsPhoto of Poudre Valley Hospital in Fort CollinsPhoto of Poudre Valley Hospital in Fort Collins

Summary

Poudre Valley Hospital is a medical facility located in Fort Collins, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Prostate Cancer, Cancer and other specialties. Poudre Valley Hospital is involved with conducting 276 clinical trials across 407 conditions. There are 29 research doctors associated with this hospital, such as Bradley R. Corr, Robert Hoyer, MD, Jose M. Pacheco, and Breelyn Wilky, M.D..

Area of expertise

1Breast Cancer
Global Leader
Poudre Valley Hospital has run 64 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive
2Lung Cancer
Global Leader
Poudre Valley Hospital has run 52 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Poudre Valley Hospital

Lung Cancer
Prostate Cancer
Breast Cancer
Bladder Cancer
Ovarian Cancer
Esophageal cancer
Breast cancer
Cancer
Kidney Cancer
Multiple Myeloma
Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Poudre Valley Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security